Good MorningEquities closed the week higher but on shaky footing following a pivot from the FOMC. Fed Chief Jerome Powell indicated the committee could slow the pace of interest rate hikes as soon as the next meeting which was what the market wanted to hear. The bad news is that inflation, labor and wage data does not support the idea that inflation is under control or that the Fed can ease off on its policy. While the committee may slow to a 50 basis point pace it should also be expected to continue hiking at that pace until inflation is indeed at 2.0%.
This week could be dicey for traders due to a lack of data on both economics and earnings. There are few notable reports due out but they are interesting on an individual basis only and unlikely to alter the big picture in any way. The takeaway is that conditions are still changing an not for the better. While labor markets remain strong and underpinned by rising wages the impact on consumer spending is getting worse at the same time. The risk is that, at some point, the scale will tip and consumer spending will contract in a meaningful way and bring the economy down with it. Featured: Buy This $5 Stock Before Apple Car Announcement (IPM) 
|
Markets | | |
After releasing an earnings report that beat analyst estimates, Okta Inc (NASDAQ: OKTA) share value shot up significantly. While not all the data was impressive, share volume still cranked up to 20.30 million—more than six times the OTKA average daily volume—to help boost the value fro... Read the Full Story |
|
From Our PartnersI'm not recommending any giant companies here...
I prefer recommending biotechs on the very forefront of massive change.
That's where all the innovation is... and the best potential for investors. | | Click here to see my biggest recommendation ever. |
|
Markets | | | ZIM Integrated Shipping Services (NYSE: ZIM) offers an example of what’s befallen the once red-hot shipping industry in the past six months. The Israel-based company’s stock is down 33.58% in the past three months and down 17.48% year-to-date.
Its wider industry has suffered a similar f... Read the Full Story |
|
Markets | | | Approaching the final week of November CSL Ltd ADR (OTCMKTS: CSLLY) received some good news as the United States Food and Drug Administration approved CSL Behring's new gene therapy drug, HEMEGENIX (etranacogene dezaparvovec-drib) for treating hemophilia B. The news helped continue the stock's upwar... Read the Full Story |
|
From Our PartnersApple is preparing to upend the auto industry with their own EV... and this $5 stock could soar 40X once it goes live! | | Click here to learn more. |
|
Markets | | | World shares are mixed and oil prices have risen after the European Union and the Group of Seven agreed on a boycott of most Russian oil and committed to a price cap of $60 per barrel on Russian exports Read the Full Story |
|
Markets | | | U.S. semiconductor producer Intel (NASDAQ: INTC) stock is trading at price levels not seen since 2016. While shares rallied after a strong earnings report, the guidance was exceptionally weak, but shares have managed to grind higher despite the warnings. The markets may have finally started to belie... Read the Full Story |
|
From Our PartnersWe are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer!
This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market. | | | | Get all the details here >>> |
|
Politics | | | Asian shares are mostly higher and oil prices also have risen after the European Union and the Group of Seven agreed on a boycott of most Russian oil and a price cap of $60 per barrel on Russian exports Read the Full Story |
|
Politics | | | India will prioritize its own energy needs and continue to buy oil from Russia, its foreign minister signaled Monday, as Western governments press Moscow with a price cap to squeeze its earnings from oil exports.
Minister of External Affairs Subrahmanyam Jaishankar made the comments a... Read the Full Story |
|
Markets | | | Customer relationship management software giant Salesforce (NASDAQ: CRM) shares tanked (-10%) on a bullish Q3 2022 earnings report but Q4 guidance was mixed. The Company beat analyst expectations as shares initially popped but then sank upon the announcement that Salesforce Co-CEO Bret Taylor would ... Read the Full Story |
|
Politics | | | Furious about oil companies' supersized profits after a summer of record-high gas prices, California Gov. Gavin Newsom on Monday will formally start his campaign to punish big producers by asking the Legislature to fine them and give the money back to drivers.
State lawmakers will bri... Read the Full Story |
|
Markets | | | “Black Panther: Wakanda Forever” kept the box-office crown for the fourth straight weekend, and the comic holiday thriller “Violent Night” debuted with $13.3 million, according to studio estimates Sunday. But the biggest talking point on the weekend was a movie conspicuously absent from theaters.
... Read the Full Story |
|
Monday's Early Bird Stock Of The Day Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland. | | View Today's Stock Pick |
|
